InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Pellegrini Niamh Louise, Executive. Insider active across 2 companies, notably NEVRO CORP. Cumulatively, 11 disclosures have been logged. History available since 6 August 2021. The latest transaction was filed on 15 June 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Pellegrini Niamh Louise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
8,400 shares0FORM 4SEC:0001628280-23-022323:0
1,143 shares@ US$26.452.0% of flowCommon StockSEC:0001610717-23-000082:0
39,282 shares0Common StockSEC:0001567619-23-004745:0
1,979 shares@ US$33.994.4% of flowCommon StockSEC:0001567619-23-004533:0
4,718 shares@ US$31.449.7% of flowCommon StockSEC:0001567619-23-004208:0
4,365 shares@ US$47.1113.9% of flowCommon StockSEC:0001567619-22-015195:0
8,400 shares0Common StockSEC:0000950103-22-010953:0
2,031 shares@ US$71.2713.0% of flowCommon StockSEC:0001567619-22-006438:0
26,069 shares0Common StockSEC:0001567619-22-006143:0
4,172 shares0Common StockSEC:0000950103-21-012267:0
4,366 shares@ US$119.7344.0% of flowCommon StockSEC:0001567619-21-014908:0
11 of 11 declarations
About Pellegrini Niamh Louise
Pellegrini Niamh Louise is an executive, Chief Commercial Officer at NEVRO CORP and Director at Acutus Medical, Inc. The file records 11 filings in total, and across the recent filings held, the most common transaction nature is Tax withholding, with a period from 2021-08-10 to 2023-06-15.
